Indeed, the LPS-induced neuroprotective effect after AIS is through the modulation of the TLR4 signaling, inhibition of NF-kB activity, and enhancement of IRF3 activity and IFN expression [131]. This evidence concerns the gene NFKB1 and androgen insensitivity syndrome.